• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR GRAFTMASTER RX CORONARY STENT GRAFT SYSTEM; CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR GRAFTMASTER RX CORONARY STENT GRAFT SYSTEM; CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1012818-19
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Angina (1710); Thrombosis/Thrombus (4440)
Event Date 06/15/2023
Event Type  Injury  
Event Description
It was reported that the procedure was performed on (b)(6) 2023 to treat a lesion in the left anterior descending (lad) coronary artery with mild calcification and mild tortuosity.The 3.0x38mm xience alpine stent delivery system (sds) was implanted; however, during post procedure review, a perforation was noted in the mid stent area; therefore, a 3.5x19mm graftmaster was implanted.On (b)(6) 2023, the patient developed chest pain and an angiography was performed, in which it was noted that the lad stented area had thrombosis due to the graftmaster.The lesion was pre-dilated with a 3.5x12mm nc trek balloon dilatation catheter (bdc) and a 2.75x18mm xience alpine sds was implanted from the mid lad to distal lad.The patient was hospitalized two days after the procedure; however, there was no adverse patient sequela.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.H6: device code 2017 clarifier: use after expiration the additional xience alpine device referenced in b5 is filed under separate medwatch report number.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.It was reported that the graftmaster was used past the expiration date.It should be noted that the graftmaster rapid exchange (rx), coronary stent graft system, domestic instructions for use (ifu) states: note the product use by date specified on the package.The expiration date of the product is important for sterility, efficacy, and performance of the device.It is likely the ifu deviation contributed to the reported event.The investigation determined the reported improper or incorrect procedure or method (device expiration issue) appears to be related to the use error.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.The reported patient effects of angina and thrombosis, as listed in the graftmaster rx coronary stent graft system ifu are known patient effects that may be associated with use of a coronary stent in native coronary arteries.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event Description
Subsequent to the previously filed report, it was determined that the device was used after the expiration date.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRAFTMASTER RX CORONARY STENT GRAFT SYSTEM
Type of Device
CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17311362
MDR Text Key319010646
Report Number2024168-2023-07435
Device Sequence Number1
Product Code MAF
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
H000001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2020
Device Catalogue Number1012818-19
Device Lot Number8062141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/21/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Other;
Patient Age62 YR
Patient SexMale
-
-